EVAKSINE AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−926k kr).
EVAKSINE AS is registered as a limited company in Oslo, Oslo with organisation number 921746318. The business is classified under other health services (NACE 86.993). The company was incorporated in 2018. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Legevirksomhet, virksomhet innen helse, e-helse, IKT, rekruttering, konsulentvirksomhet, medvirkning i andre selskaper, kjøp, salg og forvaltning av aksjer og andeler i andre selskaper, samt alt som hører naturlig til dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 4.3m in revenue and NOK 95,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns EVAKSINE AS?
EVAKSINE AS has 4 registered shareholders:
- UPNORTH INVEST AS 47.5%
- ISTRE HOLDING AS 25.7%
- DE BRUYCKER HOLDING AS 21.9%
- BJERKHOLDT HOLDING AS 5.0%
Frequently asked questions about EVAKSINE AS
Who owns EVAKSINE AS?
UPNORTH INVEST AS is the largest registered owner, with 47.5%.
What is the revenue of EVAKSINE AS?
EVAKSINE AS had revenue of NOK 4.3m in 2025.
Where is EVAKSINE AS based?
EVAKSINE AS has its business address in Oslo.
Property
107 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.